Trials / Completed
CompletedNCT01612598
Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials
Feasibility of a Palliative Care Intervention for Patients on Phase 1 Clinical Trials
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- City of Hope Medical Center · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Patients enrolled in phase I clinical trials could potentially benefit from palliative care concurrently, yet limited evidence is available to support such a change in care. The primary purpose of this study is to test the feasibility of a palliative care intervention (PCI) for patients participating in a phase I therapeutic clinical trial
Detailed description
PRIMARY OBJECTIVES: I. Describe the feasibility of implementing a PCI for patients on phase I clinical trials (study accrual and retention). II. Describe the initial impact of a PCI on key patient outcome measures (quality of life \[QOL\], psychological distress, satisfaction with communication, symptom intensity, symptom distress, and patient satisfaction) over time. OUTLINE: PCI PART I: Patients undergo comprehensive palliative care (PC) assessment based on baseline data and complete goals of care discussion. PCI PART II: Following the first dose of phase I investigational treatment, patients meet with the interdisciplinary team (IDT), where PC recommendations are made. This is followed by two patient educational sessions that will cover QOL-related domains, including physical, social, emotional, and spiritual well-being. Supportive care referrals are made based on IDT recommendations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | counseling intervention | Undergo PCI |
| PROCEDURE | quality-of-life assessment | Ancillary studies |
| OTHER | questionnaire administration | Ancillary studies |
| OTHER | educational intervention | Undergo PCI |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2013-06-01
- Completion
- 2014-01-01
- First posted
- 2012-06-06
- Last updated
- 2014-01-31
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01612598. Inclusion in this directory is not an endorsement.